Lenz & Staehelin advises TVS Motor Company in this transaction. TVS Motor Company has acquired the remaining stake in Swiss E-Mobility Group (SEMG) from Constellation Capital...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Union Investment in this transaction. PSP Swiss Property has acquired the office property “Westpark” at Pfingstweidstrasse 60 in a good location in...
You must be a Standard 1 Year member to access this content.
Emmentaler Switzerland was represented by Lenz & Staehelin with a team composed by Prof. Dr. Jürg Simon (picture), together with Prof. Dr. Cesare Galli, Milano. The...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Hasten in this transaction. Hasten Biopharmaceutic Co., Ltd acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised NCAB Group in this transaction. NCAB Group has acquired the German db electronic, based in Waldshut-Tiengen in southern Germany, the db electronic...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin acted as legal advisor to Partner One on this transaction. Partner One, one of the fastest growing enterprise software conglomerates, announced that it...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Swiss Prime Site AG in this transaction. Swiss Prime Site AG signed an agreement to sell its Wincasa group company to Implenia...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Sika in this transaction. Sika AG placed bonds in a total amount of CHF 650 million, consisting of three tranches. The payment...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advises SCCF in this transaction. SCCF Structured Commodity & Corporate Finance (“SCCF”), the Swiss-based trade finance expert, has issued short term tokenized notes...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Asceneuron in this transaction. Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron have announced the signing of a licensing...
You must be a Standard 1 Year member to access this content.
Travers Smith LLP and Walder Wyss advised Inflexion on the deal. Lenz & Staehelin advised Gyrus Capital in this transaction. Inflexion and Gyrus Capital have announced...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised XXXLutz on the deal. With over 370 furniture stores in 13 European countries, the XXXLutz Group is one of the three largest...
You must be a Standard 1 Year member to access this content.
